Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX)

136 filings reported holding NRIX - Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2022.
Nurix Therapeutics, Inc. - Common Stock, par value $0.001 per share (NRIX) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 40,367,078 shares of 77,143,980 outstanding shares and own 52% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (4,806,289 shares), Redmile Group, LLC (3,018,784 shares), BlackRock Inc. (2,524,643 shares), BAKER BROS. ADVISORS LP (2,454,082 shares), STATE STREET CORP (2,302,544 shares), VANGUARD GROUP INC (2,028,063 shares), TRV GP III, LLC (1,922,549 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,870,000 shares), WASATCH ADVISORS INC (1,546,689 shares), and PICTET ASSET MANAGEMENT SA (1,439,282 shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.